...style that dominates at Novo Nordisk is the authoritative style; this style mobilizes the team toward a common vision and focuses on end goals, leaving the means up to each individual. The authoritative style works nest for a team that is goal oriented and vision driven. I would also say the affiliation leadership style is displayed at Novo Nordisk because it’s a company that cares more than just the money. Novo Nordisk has stronger values they care about their clientele and customers and what they put out in society. The leaders at Novo Nordisk know what is most important to the company and they instill these values in their employees. When it was important to them to reduce the emission levels they worked towards that goal through caring about the people by affiliating themselves with the people and implementing authority and mobilizing the tem to achieve a goal, through doing this they succeeded in reducing emission levels as well as water consumption. Novo Nordisk’s leadership influences its organizational design and shapes its competition strategy by setting goals and implementing ways on achieving those goals. One way they try to achieve their financial goals is by understanding that people care about how the big corporations treat them as a clientele. Novo Nordisk tries to display that extra care in order for their customers to keep coming back. How a big corporation treats the environment is very important to most people therefore Novo Nordisk strategically affiliate...
Words: 383 - Pages: 2
...The decision to pursue my MBA degree was never a difficult one. When I first entered the business world in 1994 I soon knew that in order for me to achieve my personal and professional goals in life further education was going to be necessary. However, I did not think it would have taken me seventeen years to begin my journey to accomplish this goal. So far in my professional life, I would consider myself to be a success. I have worked for three companies since receiving my Bachelor of Science degree in 1994 in two different industries. I have earned accolades and awards for sales and marketing performance from all three companies and I have been told that I am seen as a leader with potential for upward mobility. After taking the Jungian 16-Type Personality test, I received a score of ISFJ. This fits right in line with my past work experience because this test shows that I am loyal and willing to make sacrifices for the greater good. I was surprised to find I was introverted because typically successful sales people are extroverts. They reach out to clients and look for ways to connect with people where introverts mostly keep to themselves. However, during the last few years my personal job satisfaction has been low and the pharmaceutical sales industry has been enduring massive layoffs (Brice, 2009). Although, my current company is somewhat “bucking the trend” regarding reducing sales force sizes, I believe that all companies are not immune to the trend. So, the...
Words: 1061 - Pages: 5
...C Marginalized APC Inc. Top 10 BioPharma Companies: Key Annual Financial Metrics APC $ (mil) Net Sales Cost of Products Sold $19,152 $5,098 26.6% % Genentech $ (mil) $36,017 $9,797 27.2% % Amgen $ (mil) $14,642 $4,070 27.8% 72.2% 18.1% 8.3% % Novo Nordisk $ (mil) $9,566 $2,506 $7,060 $1,636 $890 26.2% 73.8% 17.1% 9.3% % Merck Serono $ (mil) $7,454 $2,020 $5,434 $1,327 $581 27.1% 72.9% 17.8% 7.8% % Baxter BioScience $ (mil) $5,573 $1,494 $4,079 $1,031 $568 27% 73.2% 18.5% 10.2% % Biogen Idec $ (mil) $4,247 $1,249 $2,998 $824 $446 29.4% 70.6% 19.4% 10.5% % Genzyme $ (mil) $3,562 $1,104 $2,458 $705 $349 31.0% 69.0% 19.8% 9.8% % CSL Ltd.* $ (mil) $3,211 $967 $2,244 $581 $350 30.1% 69.9% 18.1% 10.9% % Allergan $ (mil) $1,310 $385 $925 $258 $152 29.4% 28.2% 27.0% 70.6% 71.8% 73.0% 19.7% 18.5% 17.8% 11.6% 9.8% 9.0% % Top 10 Top 5 % % Gross Margin $14,054 73.4% $26,220 Marketing, Selling and Administrative $3,508 18.3% $6,447 Advertising and Product Promotions $2,209 11.5% $2,917 Total SG&A Research and Development Operating Margin Total Expenses $5,717 29.9% $3,464 18.1% $4,873 72.8% $10,572 17.9% 8.1% $2,650 $1,215 $9,364 26.0% $6,591 18.3% 28.5% $3,865 26.4% $2,606 $4,100 17.8% 28.0% $2,525 26.4% $1,856 $2,678 19.4% 28.0% $1,908 25.6% $1,312 $2,214 17.6% 29.7% $1,599 28.7% $1,003 $1,477 18.0% 26.5% $1,270 29.9% $756 $973 17.8% 22.9% $1,054 29.6% $616 $787 17.3% 22.1% $931 29.0% $706 $607 22.0% 18.9% $410 31.3% 28.3% 26.9% $288 $227 22.0% 18.8% 18...
Words: 761 - Pages: 4
...Despite the summer, the weather was hazy on that day in May 2004 as the airplane took off from Hongqiao International Airport, Shanghai. The plane was likely to encounter some turbulence on its way to Copenhagen Airport in Denmark. The COO of the Danish shoe manufacturer ECCOA/S (ECCO), Mikael Thinghuus, did not particularly enjoy bumpy flights, but the rough flight could not overshadow the confidence and optimism he felt after his visit to Xiamen in southeast China. This was his third visit in three months. During 2003/2004, ECCO spent substantial resources on analyzing where to establish production facilities in China. On this trip, together with Flemming Brønd the production director in China, Thinghuus had finalized negotiations with Novo Nordisk Engineering (NNE). NNE possessed valuable experience in building factories in China, experience gained through their work for Novozymes...
Words: 1081 - Pages: 5
...蓝海战略 目 录 前言 致谢 第一部分 蓝海战略 第一章 开创蓝海 第二章 分析工具与框架 第二部分 制定蓝海战略 第三章 重建市场边界 第四章 关注全景，而非数字 第五章 超越现有需求 第六章 遵循合理的战略顺序 第三部分 执行蓝海战略 第七章 克服关键组织障碍 第八章 寓执行于战略 第九章 结论：蓝海战略的可持续性与更新 附录 A 蓝海战略案例纵览 附录 B 价值创新：战略的结构再造观点 附录 C 价值创新的市场动态分析 注释 参考文献 索引 1 前言 本书是友谊、忠诚和相互信赖的产物。正是友谊和信任激发我们探索本书 所表述的主要思想，并最终完成了写作。 20 年前，我们在课堂相遇——一个是教授，一个是学生。从那时起，我们 就一直一起工作，犹如同一条下水道里的两只湿老鼠。因此，本书不是思想的成 功，而是友谊的成功，并且我们发现友谊比商业世界的任何思想都更有意义—— 因为我们不是孤军奋战。 任何旅途都不是一帆风顺的，任何友谊也不会仅仅充满了欢笑。好在写作 的旅途上，我们的每一天都是激动人心的，因为我们在完成一项旨在学习和改进 的任务。我们深信本书的思想，这些思想绝非为那些得过且过或生活目标仅仅在 于混日子的人所准备；因为那不是我们的兴趣。如果你仅满足于上述生活态度， 请不必阅读本书，但是如果你想干一番事业，想建立一家客户、雇员、股东以及 社会共赢的企业，请读下去。尽管这并非易事，但却值得去做。 我们的研究认为，任何一家企业都不可能永葆卓越，正如任何一个行业都 无法长盛不衰一样。我们回顾走过的路时会发现，自己和企业一样，做了聪明的 事和蠢事。为了更加成功，我们需要研究和认识造成积极变化的那些行为，以及 如何才能系统性地复制此类正确的行为。这就是我们所说的聪明的战略推动，并 且我们发现，起中心作用的战略行为就是开创蓝海。 蓝海战略要求企业突破传统的血腥竞争所形成的“红海”，拓展新的非竞争 性的市场空间。与已有的、通常呈收缩趋势的竞争市场需求不同，蓝海战略考虑 的是如何创造需求，突破竞争。本书不仅仅对企业思维进行挑战，而且告诉它们 怎样达到目标。首先，我们引入一整套分析工具与框架，告诉读者如何系统性地 应对挑战；其次，我们阐明了若干原则，以区分蓝海战略和传统竞争性战略。 我们的目标是在当前的已知市场空间的“红海”竞争之外，构筑系统性、 可操作的蓝海战略，并加以执行。只有这样，企业才能以明智和负责的方式拓展 蓝海领域，同时实现机会的最大化和风险的最小化。任何一家企业，无论其规模 大小， 是已有的行业企业， 还是新进入该行业的企业， 都不应， 也不能过度冒险 。 本书的内容是 15 年研究的总结，使用的数据区间在百年以上，还包括与此 观点有关的《哈佛商业评论》的一系列文章和其他相关学术文章。本书所阐述的 2 理念、 工具和思想框架在欧美和亚洲的企业中已经经过了多年的实践检验与不断 的更新。本书的阐述将上述的工作和思想汇总到一个统一框架之内。这一框架不 仅仅包括对如何蓝海战略的分析，还对最重要的人事问题作出解答，以使组织和 人员自觉贯彻执行这些思想。在此，我们将如何赢得信任和忠诚，以及理解员工 理性与感性认知的重要性，摆在了蓝海战略的核心位置。 蓝色海洋的机遇已经展现。随着对蓝海领域的探索，市场的空间不断扩展。 我们相信，这种扩张正是企业发展的根源。然而，对于如何有系统地创造和开辟 蓝海领域，无论在理论上还是实践上都还有所不足。我们诚邀读者阅读本书，学 会成为未来增长的驾驭者。 3 致谢 本书的写作得到了不少协助。INSEAD 提供了独一无二的研究环境，在此，...
Words: 12975 - Pages: 52
...Question 1: Considering both economic and ethical aspects, is it appropriate for companies like Novo Nordisk to conduct clinical trials in, for example, India, and if so under what conditions? What exactly are the principles that should guide such a decision? 1. Ethical aspect. Nordisk’s implementation of clinical trials in India is appropriate. The appropriateness is expressed through the following guidelines: • Novo Nordisk’s trials seriously comply with medical ethics (Hippocrates’s oath) through its particular attention to individual patients joining any of its trials. • Novo Nordisk has applied all the guidelines and global recommendations from specialized agencies and has adopted its policies on clinical trials. Accordingly: o Clinical trials sponsored by the company always comply with Helsinki Declaration, listing the rights of patients enrolled in clinical trials, and the global ethical principles like Nuremberd rules, and Belmont report, CIOMMS and the principles of the International Conference of Harmonization on Current Clinical Practice (CGCP) o Countries where Novo Nordisk conducts trials will be ensured to have a proper internal organization and proper legal environment. o No testing activities are conducted before permitted by the ethics review board and the health authorities. o The safety information of Novo Nordisk’s trials will be continuously monitored and appropriate actions will be taken if risks of the tried medicine outweigh the benefits it brings...
Words: 1295 - Pages: 6
...Ethics of Offshoring: Novo Nordisk and Clinical Trials In Emerging Economies Offshoring is a highly debatable topic throughout the country and the world. Many people base their opinions on different aspects of offshoring. Some people are against offshoring because they feel as if the working conditions in other countries aren’t up to par and are unethical. Some people are against offshoring because they feel it is taking jobs away from people within their own country. Some people are for offshoring because they feel there is greater profit involved or that they can get harder workers in other countries. No matter what side of the debate, everyone can agree on a few things like there needs to be better standards for working conditions, proper safety measures, and high economic and ethical concern. The case Ethics of Offshoring: Novo Nordisk and Clinical Trials in Emerging Economies was a highly informative case on clinical trials and offshoring. There was a reporter who wanted to speak with Anders Dejgaard, chief medical officer of Novo Nordisk, about his take on the offshoring of clinical trials by Danish companies as there had been multiple reports about trials being conducted in developing countries under unethical conditions. When reading the case, it truly made me consider aspects that I had never considered before. There are a few underlying questions that I feel need to be discussed. First of all, when considering both economic and ethical aspects, is it appropriate...
Words: 1572 - Pages: 7
...The Village of Manlius is located 30 minutes outside of the City of Syracuse. The land was settled in the late 1700s and grew out of the almost endless farmable soil, and surrounding water sources. Kathy Crowell a former Town and Village of Manlius historian wrote multiple articles that share her discoveries. Her work revealed that the towns’ population was not recorded in the US census until the early 1900s. The first 1314 individuals of the village were documented in 1913 in cooperation with the US census. On April 30, 1842 Manlius was incorporated as the Village of Manlius, shortly following the first village officials were selected. It wasn’t until 1985 that the three villages of Fayetteville, Manlius, and Minoa united as one, creating the Town of Manlius (Fayetteville And Its Industries). Above: A picture of the Town of Manlius depicting the three villages in proximity to each other. Above: A picture of the Town of Manlius depicting the three villages in proximity to each other. As noted above the three villages maintained their own police departments, post offices, and residential structures, but through a municipal agreement, the villages unified to eliminate duplicate services, improve delivery and transportation routes, as well as promote town-planning standards (Lowenberg). The Village of Manlius within the greater of the Town, has a diverse and rich history that was established through the migration, settlement, and evolution of the three villages. The...
Words: 1433 - Pages: 6
...has arisen over years. Being a leading company in biopharmaceutical industry, Novo Nordisk faces the critiques of whether it is justice to offshoring their clinical trials in developing economies. With the consistency of ethical principles brought up by Novo Nordisk, the company would be able to move their trials into emerging economies with the best interest for stakeholders. I will also propose ideas to Mr, Dejgaard for possible approach to media as well as the practices that Novo Nordisk could have changed over time at the end. Conducting Clinical Trials in Emerging Economies With Utilitarian approach, every party has different perspectives in the outcome of an action. In this case, we have shareholders, employees, customers, supply chain, government and local communities, with secondary stakeholders of media, special interest groups and NGOs. For customers, government and local communities, they emphasize more on the proof of efficacy and safety of medical products. While shareholders, employees, supply chain care more of the profitability as a whole in general. As a result, Novo Nordisk will be better off maximizing its profits while holding their ethical justice for conducting clinical trials in emerging countries. Economic Aspect As the Nobel prize winner, Milton Friedman pointed out that making profit will be the first priority for business to fulfill social responsibility, Novo Nordisk has every right to maximize its best interest for its stakeholders include shareholders...
Words: 919 - Pages: 4
...Hector Morales Economic Supply and Demand Analysis Novo Nordisk has offered a significant amount of data involving their manufacturing of insulin to the general public. They have estimated that as populations change and diabetes is moving more into the cities we will find that two out of three people that have diabetes will reside in the city. “By 2030, it is estimated that more than half a billion people will suffer from diabetes with nearly two-thirds of everyone with diabetes living in cities, and those who move to cities are significantly more likely to develop diabetes than those who remain in rural settings” (Novo Nordisk, 2013). Census now show that more people now reside in the city than in the rural areas of the country. Now the population is at 52% and is thought to rise to 70% by the year 2050. Because of the economic strength and higher consumption, to inactive lifestyles and the inability to obtain good health care has given rise to the higher numbers of diabetes in our country. One of the main concerns of diabetic patients remains how they will pay for the necessary medications and supplies needed. In my research I have found that without insurance it can be relatively expensive especially for those on fixed incomes. The estimated prices for a vial of novo log insulin ranges from $143.00 to 200.00, 3 flex pens of novo log $207.00 to $250.00, and 3 cartridges $203.00 to $215.00. Novo Nordisk states that it works to ensure that prices are not excessive...
Words: 1048 - Pages: 5
...Question 1: Considering both economic and ethical aspects, is it appropriate for companies like Novo Nordisk to conduct clinical trials in, for example, India, and if so under what conditions? What exactly are the principles that should guide such a decision? 1. Ethical aspect. Nordisk’s implementation of clinical trials in India is appropriate. The appropriateness is expressed through the following guidelines: • Novo Nordisk’s trials seriously comply with medical ethics (Hippocrates’s oath) through its particular attention to individual patients joining any of its trials. • Novo Nordisk has applied all the guidelines and global recommendations from specialized agencies and has adopted its policies on clinical trials. Accordingly: o Clinical trials sponsored by the company always comply with Helsinki Declaration, listing the rights of patients enrolled in clinical trials, and the global ethical principles like Nuremberd rules, and Belmont report, CIOMMS and the principles of the International Conference of Harmonization on Current Clinical Practice (CGCP) o Countries where Novo Nordisk conducts trials will be ensured to have a proper internal organization and proper legal environment. o No testing activities are conducted before permitted by the ethics review board and the health authorities. o The safety information of Novo Nordisk’s trials will be continuously monitored and appropriate actions will be taken if risks of the tried medicine outweigh the...
Words: 373 - Pages: 2
...Executive Summary The diabetes market is expected to be over 500M cases by 2030. Sanofi’s Lantus has over 40% of the basal insulin market is the global leader in the diabetes solution space. However, came off patent in February 2015 and is at risk for competition from Eli Lilly. Sanofi needed to round out its diabetes portfolio and make up for lost revenue so it looked for an unmet consumer need. Afrezza helps Sanofi diversify its diabetes portfolio. Afrezza, is an inhalable insulin. It differentiates itself by providing a less painful and more convenient method of insulin administration for many patients. While the primary goal is to diversify itself from competition and generating lost revenues from Lantus , the greater opportunity lies in bringing transforming the diabetes solutions space. Overview of Diabetes Market As of 2014, there were 387M cases of diabetes worldwide which caused an estimated 1.5 million deaths globally. Diabetes is a chronic condition that has to be managed daily as it cannot be cured. Diabetes is the leading cause of amputations, blindness and many other health problems. The number of diabetes cases worldwide is expected to grow by an additional 205M cases by year 2030. There is a large financial incentive for companies to get into this space. As of 2012, the global insulin market was valued at $20B growing at a CAGR of 5.09% to $54B in 2030. Many of the new diabetes patients will have Type II and more and more Type II patients are using...
Words: 1200 - Pages: 5
...MULTIPLE CHOICE (CHAPTER 4) 1. Using a sample of 100 consumers, a double-log regression model was used to estimate demand for gasoline. Standard errors of the coefficients appear in the parentheses below the coefficients. Ln Q = 2.45 -0.67 Ln P + . 45 Ln Y - .34 Ln Pcars (.20) (.10) (.25) Where Q is gallons demanded, P is price per gallon, Y is disposable income, and Pcars is a price index for cars. Based on this information, which is NOT correct? a. Gasoline is inelastic. b. Gasoline is a normal good. c. Cars and gasoline appear to be mild complements. d. The coefficient on the price of cars (Pcars) is insignificant. e. All of the coefficients are insignificant. 2. In a cross section regression of 48 states, the following linear demand for per-capita cans of soda was found: Cans = 159.17 – 102.56 Price + 1.00 Income + 3.94Temp | |Coefficients |Standard Error |t Stat | |Intercept |159.17 |94.16 |1.69 | |Price |-102.56 |33.25 |-3.08 | |Income |1.00 |1.77 |0.57 | |Temperature |3.94 |0.82 |4.83 | R-Sq = 54.1% R-Sq(adj) = 51.0% From the linear regression results in the cans case...
Words: 1651 - Pages: 7
...an important source of energy for the cells that make up your muscles and tissues.” There are two types of diabetes there is Type 1 and Type 2 diabetes. The main difference between the two is Type 1 your body is unable to produce insulin, in Type 2 it can be cured through diet and exercise. Hypoglycemia is a major fear for among diabetics this is when you are low on blood sugar and this triggers symptoms such as: rapid/fast heartbeat, fatigue, headaches, shakiness, blurred vision, weakness, unconsciousness, etc. I did some research and found that there are actually people who are athletes that still are able to play a sport or even stay active. Team Novo Nordisk is a group diabetic athletes that compete each year in triathlons, cycling, and runners. They have competed in more than 500 events worldwide in 2014. Team Novo Nordisk started back in 2006 with only eight members now it is composed of 100 athletes from 20 different countries. The reason why the compete each year is not only to educate people about diabetes but also to inspire people with diabetes. Many of their athletes are great and have accomplished a lot in their life. Reading some of their stories are inspirational, for example Benny Madrigal is a teacher, a father, and a competitive athlete. He was diagnosed at 22 and he felt lost at first and didn’t know anything about diabetes. In the last five years since his diagnosis he has won a couple of races and has set...
Words: 743 - Pages: 3
...MULTIPLE CHOICE (CHAPTER 4) 1. Using a sample of 100 consumers, a double-log regression model was used to estimate demand for gasoline. Standard errors of the coefficients appear in the parentheses below the coefficients. Ln Q = 2.45 -0.67 Ln P + . 45 Ln Y - .34 Ln Pcars (.20) (.10) (.25) Where Q is gallons demanded, P is price per gallon, Y is disposable income, and Pcars is a price index for cars. Based on this information, which is NOT correct? a. Gasoline is inelastic. b. Gasoline is a normal good. c. Cars and gasoline appear to be mild complements. d. The coefficient on the price of cars (Pcars) is insignificant. e. All of the coefficients are insignificant. 2. In a cross section regression of 48 states, the following linear demand for per-capita cans of soda was found: Cans = 159.17 – 102.56 Price + 1.00 Income + 3.94Temp | |Coefficients |Standard Error |t Stat | |Intercept |159.17 |94.16 |1.69 | |Price |-102.56 |33.25 |-3.08 | |Income |1.00 |1.77 |0.57 | |Temperature |3.94 |0.82 |4.83 | R-Sq = 54.1% R-Sq(adj) = 51.0% From the linear regression results in the cans case...
Words: 1651 - Pages: 7
